Both the rituximab dose and maintenance immunosuppression in steroid-dependent/frequently-relapsing nephrotic syndrome have important effects on outcomesEugene Yu-hin Chan, Kjell Tullus, Markus J. Kemper et al.|Kidney International|2019Cited by 119
Efficacy and Safety of Rituximab Therapy to Sustain Remission in Young Children With Childhood Nephrotic SyndromeEugene Yu-hin Chan, Kjell Tullus, Chun Ting Au et al.|Kidney International Reports|2026Cited by 1